|
?:abstract
|
-
Who this guidance is for: use by federal, state, and local public health officials, respiratory protection program managers, occupational health service leaders, infection prevention and control program leaders, and other leaders in healthcare settings who are responsible for developing and implementing policies and procedures for preventing pathogen transmission in healthcare settings Purpose: This webpage describes considerations for the use of powered air-purifying respirators (PAPRs) to provide respiratory protection to healthcare practitioners (HCP) as a component of a formally developed and implemented written respiratory protection program It addresses conventional, contingency, and crisis surge PAPR use and maintenance practices This interim guidance is based on what is currently known about the transmission and severity of coronavirus disease 2019 (COVID-19) The US Centers for Disease Control and Prevention (CDC) will update this guidance as needed and as additional information becomes available Please check the CDC COVID-19 website periodically for updated interim guidance Conventional capacity strategies should be incorporated into everyday practices Contingency capacity strategies should be used when shortages are predicted but supplies are available Crisis capacity strategies should be used during known shortages
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}